Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis

被引：4
|
作者：
Raju, R [1 ]
Zhan, WZ
Karachunski, P
Sieck, GC
Conti-Fine, BM
David, CS
机构：
[1] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Anesthesiol Res, Rochester, MN 55905 USA
[3] Univ Minnesota, Dept Biochem, St Paul, MN 55108 USA
来源：
MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION | 1998年 / 841卷
关键词：
D O I：
10.1111/j.1749-6632.1998.tb10947.x
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：360 / 364
页数：5
相关论文
共 50 条
  • [1] Ocular myasthenia gravis induced by human acetylcholine receptor ε subunit immunization in HLA DR3 transgenic mice
    Wu, Xiaorong
    Tuzun, Erdem
    Saini, Shamsher S.
    Wang, Jun
    Li, Jing
    Aguilera-Aguirre, Leopoldo
    Huda, Ruksana
    Christadoss, Premkumar
    IMMUNOLOGY LETTERS, 2015, 168 (02) : 306 - 312
  • [2] Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis
    Raju, R
    Zhan, WZ
    Karachunski, P
    Conti-Fine, B
    Sieck, GC
    David, C
    JOURNAL OF IMMUNOLOGY, 1998, 160 (09): : 4169 - 4174
  • [3] HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: Definitive association with HLA-DRB1*0301 (DR3) gene
    Kong, YCM
    Lomo, LC
    Motte, RW
    Giraldo, AA
    Baisch, J
    Strauss, G
    Hammerling, GJ
    David, CS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 1167 - 1172
  • [4] HLA class II molecules and AChR subunit immunity determine ocular myasthenia gravis susceptibility in HLA transgenic mice
    Christadoss, P
    Bednov, A
    Saini, SS
    Tuzun, E
    Yang, H
    NEUROLOGY, 2006, 66 (05) : A256 - A256
  • [5] HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible
    Wan, Q
    Shah, R
    Panos, JC
    Giraldo, AA
    David, CS
    Kong, YCM
    HUMAN IMMUNOLOGY, 2002, 63 (04) : 301 - 310
  • [6] Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies
    Chen, D
    Ueda, R
    Harding, F
    Patil, N
    Mao, W
    Kurahara, C
    Platenburg, G
    Huang, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) : 172 - 182
  • [7] Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis
    Das, P
    Drescher, KM
    Geluk, A
    Bradley, DS
    Rodriguez, M
    David, CS
    HUMAN IMMUNOLOGY, 2000, 61 (03) : 279 - 289
  • [8] Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis
    Hoedemaekers, A
    Bessereau, JL
    Graus, Y
    Guyon, T
    Changeux, JP
    Berrih-Aknin, S
    Vriesman, PV
    De Baets, MH
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 89 (1-2) : 131 - 141
  • [9] Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors
    Yang, H
    Goluszko, E
    David, C
    Okita, DK
    Conti-Fine, B
    Chan, TS
    Poussin, MA
    Christadoss, P
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 375 - 378
  • [10] Gene expression profile of experimental autoimmune myasthenia gravis in passive induction experimental autoimmune myasthenia gravis
    Kaminski, HJ
    Hughes, B
    Porter, J
    Merriam, A
    Gong, B
    Richmonds, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
12345